Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPRENORPHINE vs BUPROPION\NALTREXONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPRENORPHINE vs BUPROPION\NALTREXONE: Safety Overview

Metric BUPRENORPHINE BUPROPION\NALTREXONE
Total FAERS Reports 82,047 7,763
Deaths Reported 25,813 30
Death Rate 31.5% 0.4%
Hospitalizations 9,467 628
Average Patient Age 47.5 yrs 50.0 yrs
% Female Patients 52.6% 87.6%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Dr.Reddys Laboratories Inc N/A
Route BUCCAL N/A
Marketing Status Discontinued N/A